# POS02_SEMANTIC_DEFINITION_V1

## Query
"Does statin interact with aspirin?"

## Expected Proposition from Amended Evidence
"No clinically significant pharmacokinetic drug-drug interactions have been observed when atorvastatin is co-administered with aspirin."

## Semantic Intended Meaning
POS-02 is intended to test the system's **ability to retrieve authoritative evidence answering the interaction question**, rather than blindly confirming the existence of a positive interaction. The amended evidence supports a **bounded negative conclusion** regarding clinical and pharmacokinetic interactions, which is the correct pharmacological answer. 

If POS-02 was originally meant to strictly require a positive interaction finding (e.g. testing the system's ability to extract risk warnings), then the current FDA evidence fundamentally changes the semantic expected outcome of POS-02 from a Positive Interaction to a Bounded Negative finding. The protocol must formally accept a Bounded Negative finding as a valid positive control for retrieval effectiveness.
